Is it worthwhile adding glitazone therapy to insulin-treated Type 2 patients in poor glycaemic control? A prospective audit

被引:0
|
作者
Levy, D. [1 ]
Liew, L. [1 ]
Barron, B. [1 ]
Manogaraan, B. [1 ]
Reilly, P. [1 ]
机构
[1] Whipps Cross Univ Hosp, Dept Endocrinol & Diabet, London, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:66 / 66
页数:1
相关论文
共 50 条
  • [41] The impact of acute glycaemic fluctuations on left ventricular systolic function in insulin-treated type 2 diabetes
    Andersen, A.
    Jorgensen, P. G.
    Bagger, J. I.
    Baldassarre, M. P. A.
    Christensen, M.
    Abelin, K. U.
    Faber, J.
    Pedersen-Bjergaard, U.
    Holst, J. J.
    Lindhardt, T.
    Gislason, G.
    Knop, F. K.
    Vilsboll, T.
    DIABETOLOGIA, 2020, 63 (SUPPL 1) : S429 - S429
  • [42] Glycaemic variability and hypoglycaemia are associated with C-peptide levels in insulin-treated type 2 diabetes
    Christensen, M. B.
    Gaede, P.
    Hommel, E.
    Gotfredsen, A.
    Norgaard, K.
    DIABETES & METABOLISM, 2020, 46 (01) : 61 - 65
  • [43] The impact of bariatric surgery on insulin-treated type 2 diabetes patients
    Lemus, Rodrigo
    Karni, Dror
    Hong, Dennis
    Gmora, Scott
    Breau, Ruth
    Anvari, Mehran
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2018, 32 (02): : 990 - 1001
  • [44] Amputations and mortality in elderly insulin-treated patients with type 2 diabetes
    Spraul, M
    Schönbach, AM
    Mühlhauser, I
    Berger, M
    ZENTRALBLATT FUR CHIRURGIE, 1999, 124 (06): : 501 - 507
  • [45] Efficacy and safety of acarbose in insulin-treated patients with type 2 diabetes
    Kelley, DE
    Bidot, P
    Freedman, Z
    Haag, B
    Podlecki, D
    Rendell, M
    Schimel, D
    Weiss, S
    Taylor, T
    Krol, A
    Magner, J
    DIABETES CARE, 1998, 21 (12) : 2056 - 2061
  • [46] The impact of bariatric surgery on insulin-treated type 2 diabetes patients
    Rodrigo Lemus
    Dror Karni
    Dennis Hong
    Scott Gmora
    Ruth Breau
    Mehran Anvari
    Surgical Endoscopy, 2018, 32 : 990 - 1001
  • [47] Sarcopenia in Insulin-Treated Older Adult Patients with Type 2 Diabetes
    Leite, Silmara A. O.
    Bastos, Murilo
    Silva, Michael
    Lavalle, Ana C. R.
    Bertogy, Maria C.
    Vieira, Suelen C.
    Umpierrez, Guillermo E.
    DIABETES, 2022, 71
  • [48] Metformin and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients
    Monami, Matteo
    Colombi, Claudia
    Balzi, Daniela
    Dicembrini, Ilaria
    Giannini, Stefano
    Melani, Cecilia
    Vitale, Valentina
    Romano, Desiderio
    Barchielli, Alessandro
    Marchionni, Niccolo
    Rotella, Carlo Maria
    Mannucci, Edoardo
    DIABETES CARE, 2011, 34 (01) : 129 - 131
  • [49] Cancer Specific Mortality in Insulin-Treated Type 2 Diabetes Patients
    Ioacara, Sorin
    Guja, Cristian
    Ionescu-Tirgoviste, Constantin
    Fica, Simona
    Roden, Michael
    PLOS ONE, 2014, 9 (03):
  • [50] A comparison of adding proglitazone or insulin to patients with type 2 diabetes in poor control on maximal doses of sulphonylurea and metformin: A prospective Randomized trial
    Jabri, K
    Kozak, S
    Thompson, D
    DIABETES, 2003, 52 : A109 - A109